Tag Archives: pseudomonas aeruginosa

Treating bandages with enzymes and polyethylene glycol or cellulase* could make antibacterial nanoparticles better adhere

It’s been a while since I’ve featured research from Iran. This work is focused on bandages, burns, and nanoparticles according to an Oct. 18, 2016 news item on Nanowerk (Note: A link has been removed),

Pre-treating the fabric surface of the bandages used to treat burns with enzymes and polyethylene glycol or cellulase may promote the adhesion of antibacterial nanoparticles and improve their bacteria-repelling ability. These are the findings of a group of scientists from the Islamic Azad University, Iran, published in The Journal of The Textile Institute (“NiO-/cotton- modified nanocomposite as a medication model for bacterial-related burn infection”).

An Oct. 18, 2016 Taylor & Francis (Publishing) Group press release (received via email), which originated the news item, expands on the theme,

Injuries caused by burns are a global health problem, with the World Health Organisation citing 195,000 deaths per year worldwide as a result of burns from fires alone. Burn injuries are particularly susceptible to infections, hospital-acquired or otherwise, with the bacteria Pseudomonas aeruginosa accounting for over half of all severe burn infections.

Noble metal (particularly silver) antimicrobials have long been identified as having potential for combating bacterial infection; however, there are concerns about dressings adhering to wounds and toxic effects on skin cells. Currently, scientists are researching nanoparticles which can be used to introduce these antimicrobial properties into the textiles used in dressings.

The authors of this paper have studied 150 cases to identify the most common infections in burns. In the paper, they also identified a method for giving cotton bandages antibacterial properties by coating the fabric surface with a Nickel oxide (NiO)/organic polymer/enzyme matrix in order to promote their bacteria-resistant qualities and suitability for use on burn victims.

Pseudomonas and Staphylococci infections emerged as the two most common pathogens in the Iran Burn Centre, where the study took place, and the authors evaluated their design of the bandage against these as well as fifteen other strains of bacteria. They conclude by proposing further studies into the combination of bactericidal polymers with bacteria-killing metal-oxide nanoparticles in cotton fabrics. Whilst their current design does not meet the criteria for a susceptibility test, they are hopeful that further studies will reveal the clinical relevance of their design.

Here’s a link to and a citation for the paper,

NiO-/cotton- modified nanocomposite as a medication model for bacterial-related burn infections by Azadeh Basiri, Nasrin Talebian & Monir Doudi. The Journal of The Textile Institute http://dx.doi.org/10.1080/00405000.2016.1222863
Pages 1-9 Published online: 12 Sep 2016

This paper is behind a paywall.

*’Cellulase’ changed to ‘Cellulose’ Nov. 15, 2016 at 1832 PT and changed back again on Nov. 16, 2016. Sorry for the confusion but by the time I published this piece I’d forgotten checking to confirm the existence of cellulase.

Greening silver nanoparticles with lignin

A July 13, 2015 news item on phys.org highlights a new approach to making silver nanoparticles safer in the environment,

North Carolina State University researchers have developed an effective and environmentally benign method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells. The findings introduce ideas for better, greener and safer nanotechnology and could lead to enhanced efficiency of antimicrobial products used in agriculture and personal care.

A July 13, 2015 North Carolina State University (NCSU) news release (also on EurekAlert), which originated the news item, adds a bit more information,

As the nanoparticles wipe out the targeted bacteria, they become depleted of silver. The remaining particles degrade easily after disposal because of their biocompatible lignin core, limiting the risk to the environment.

“People have been interested in using silver nanoparticles for antimicrobial purposes, but there are lingering concerns about their environmental impact due to the long-term effects of the used metal nanoparticles released in the environment,” said Velev, INVISTA Professor of Chemical and Biomolecular Engineering at NC State and the paper’s corresponding author. “We show here an inexpensive and environmentally responsible method to make effective antimicrobials with biomaterial cores.”

The researchers used the nanoparticles to attack E. coli, a bacterium that causes food poisoning; Pseudomonas aeruginosa, a common disease-causing bacterium; Ralstonia, a genus of bacteria containing numerous soil-borne pathogen species; and Staphylococcus epidermis, a bacterium that can cause harmful biofilms on plastics – like catheters – in the human body. The nanoparticles were effective against all the bacteria.

The method allows researchers the flexibility to change the nanoparticle recipe in order to target specific microbes. Alexander Richter, the paper’s first author and an NC State Ph.D. candidate who won a 2015 Lemelson-MIT prize, says that the particles could be the basis for reduced risk pesticide products with reduced cost and minimized environmental impact.

“We expect this method to have a broad impact,” Richter said. “We may include less of the antimicrobial ingredient without losing effectiveness while at the same time using an inexpensive technique that has a lower environmental burden. We are now working to scale up the process to synthesize the particles under continuous flow conditions.”

I don’t quite understand how the silver nanoparticles/ions are rendered greener. I gather the lignin is harmless but where do the silver nanoparticles/ions go after they’ve been stripped of their lignin cover and have killed the bacteria? I did try reading the paper’s abstract (not much use for someone with my science level),

Silver nanoparticles have antibacterial properties, but their use has been a cause for concern because they persist in the environment. Here, we show that lignin nanoparticles infused with silver ions and coated with a cationic polyelectrolyte layer form a biodegradable and green alternative to silver nanoparticles. The polyelectrolyte layer promotes the adhesion of the particles to bacterial cell membranes and, together with silver ions, can kill a broad spectrum of bacteria, including Escherichia coli, Pseudomonas aeruginosa and quaternary-amine-resistant Ralstonia sp. Ion depletion studies have shown that the bioactivity of these nanoparticles is time-limited because of the desorption of silver ions. High-throughput bioactivity screening did not reveal increased toxicity of the particles when compared to an equivalent mass of metallic silver nanoparticles or silver nitrate solution. Our results demonstrate that the application of green chemistry principles may allow the synthesis of nanoparticles with biodegradable cores that have higher antimicrobial activity and smaller environmental impact than metallic silver nanoparticles.

If you can explain what happens to the silver nanoparticles, please let me know.

Meanwhile, here’s a link to and a citation for the paper,

An environmentally benign antimicrobial nanoparticle based on a silver-infused lignin core by Alexander P. Richter, Joseph S. Brown, Bhuvnesh Bharti, Amy Wang, Sumit Gangwal, Keith Houck, Elaine A. Cohen Hubal, Vesselin N. Paunov, Simeon D. Stoyanov, & Orlin D. Velev. Nature Nanotechnology (2015) doi:10.1038/nnano.2015.141 Published online 13 July 2015

This paper is behind a paywall.

New molecular ruler could help with developing antibiotics

Researchers at the University of Utah have developed a molecular ruler which could help to determine the length at which a nanoscale needle is effective. From a March 17, 2015 news item on Azonano,

When a salmonella bacterium attacks a cell, it uses a nanoscopic needle to inject it with proteins to aid the infection. If the needle is too short, the cell won’t be infected. Too long, and the needle breaks. Now, University of Utah biologists report how a disposable molecular ruler or tape measure determines the length of the bacterial needle so it is just right.

The findings have potential long-term applications for developing new antibiotics against salmonella and certain other disease-causing bacteria, for designing bacteria that could inject cancer cells with chemotherapy drugs, and for helping people how to design machines at the nanoscopic or molecular scale.

A March 16, 2015 University of Utah news release, which originated the news item, provides some insight from the researchers,

“If you look at important pathogens – the bubonic plague bacterium, salmonella, shigella and plant pathogens like fire blight – they all use hypodermic-like needles to inject proteins that facilitate disease processes,” Hughes [University of Utah biology professor Kelly Hughes] says.

“Our work says that there is one mechanism – the molecular ruler – to explain how the lengths are controlled for needles in gram-negative bacteria and for hooks on flagella [the U-joints in propellers bacteria use to move] in all bacteria,” he adds.

In their study, Wee [University of Utah doctoral student Daniel Wee] and Hughes found that as a bacterial needle or “injectisome” grows, a molecular ruler – really, more like a gooey tape measure – is secreted from within the needle’s base. It oozes up through the tube-like needle, and when the bottom end of the ruler reaches the bottom end of the needle, the needle stops growing and begins to inject proteins into the target cell to help the infection process.

The biologists say the [US] National Institutes of Health-funded study refutes other theories for how salmonella and some other disease bacteria determine needle lengths.

The news release also explains how this finding could be made useful,

“What we understand from bacteria can help us build nanomachines and nanobots,” Hughes says, noting that bacterial flagella – the nanoscopic motor-and-propeller system they use to swim to dinner or to targets – are “the most sophisticated nanomachines in the universe.”

In one example, Swiss scientists are using the design of bacterial flagella as the basis for a nanobot that will be put inside the eye to do nanoscale surgery, he adds.

In addition to flagella, a number of disease-causing bacteria also have injectisomes, which also are built of proteins, as are most structures in living organisms.

“In the case of the needle, you have a structure that extends from the surface of the bacterium like a hypodermic,” Hughes says. “These needles are fragile. If one is too long, it will break off and be useless. If you make it too short, then it can’t get past the surface proteins on cells it needs to invade.”

By understanding how bacteria determine the length for their needles, it someday may be possible to engineer bacteria to inject chemotherapy drugs right into cancer cells.

“People would like to design bacteria that can get to cancer cells and inject poisons into just those cells and kill them, and not harm the rest of us,” Hughes says.

And by understanding how certain disease-causing bacteria build their injectisomes, new antibiotics might be developed in a decade or so to target and destroy the needles and thus deter bacterial infections. The rulers that help build flagella also might be attacked by drugs to prevent bacteria from reaching target cells, “so you can kill two birds with one stone by hitting the two machines at the same time,” Hughes says.

He says that approach might work against injectisome-equipped bacteria such as salmonella species that cause typhoid fever and food poisoning; shigella species that cause dysentery; the bubonic plague bacterium Yersinia pestis; disease-causing E. coli; sexually transmitted Chlamydia trachomatis; many plant pathogens; and Pseudomonas aeruginosa, which often infects burn patients and the lungs of cystic fibrosis patients.

Not usually my kind of thing, I find this quite fascinating (from the news release),

Bacteria secrete a molecular ruler to measure needle length

Bacterial injectisomes are incredibly small, measuring only 20 to 100 nanometers long. A nanometer is one billionth of a meter, and a meter is about 39 inches long. The width of a typical human hair often is given as 100 microns, so the maximum length of a bacterial needle, 100 nanometers, is one-thousandth of the width of a human hair.

Gram-negative, disease-causing bacteria “are very closely related species, so how do they subtly control the various needle lengths to be perfect?” Hughes asks. “In one case it might be 40 nanometers versus 55 nanometers. These are small sizes. So to do this, the bacteria developed molecular rulers to differentiate needles of different lengths.”

(Gram-negative bacteria are those with membranes lining both the inside and outside of their cell wall, while gram-positive bacteria have only an inner membrane.)

Like any cell, a bacterium is encased in a cell wall. So bacteria developed all kinds of secretions to make contact with and infect other cells: flagellar propellers to swim to food or target cells, docking structures to help bacteria stick to targets, and injectisomes to inject infection-promoting proteins into targets.

When a bacterium builds a needle, it first builds a base. “A series of proteins form a doughnut, and inside the doughnut hole, the actual secretion machine gets constructed,” Hughes says. “It’s the same for the flagella as it is for these needles.”

Next, proteins start assembling to form the needle or injectisome.

The new study demonstrated that in salmonella, the ruler or tape measure is secreted slowly through the channel of the growing needle. Once amino acids at the bottom end of the ruler pass through the base of the needle, they tell the bacterium that the needle is long enough and to stop growing. They also tell the needle to injecting virulence proteins into the target cell, and the molecular ruler is ejected, Wee says.

Here’s an image of what the injectisome looks like,

On the left is an electron microscope image of an injectisome, the nanoscopic needle that salmonella and certain other bacteria use to inject proteins into target cells as part of the infection process. The illustration at center depicts the exterior of the needle and its base. The cross-section at right shows the string-like molecular ruler that determines the length of salmonella’s bacteria needle, according to a new University of Utah study by doctoral student Daniel Wee and biology professor Kelly Hughes. Credit: Daniel Wee, University of Utah

On the left is an electron microscope image of an injectisome, the nanoscopic needle that salmonella and certain other bacteria use to inject proteins into target cells as part of the infection process. The illustration at center depicts the exterior of the needle and its base. The cross-section at right shows the string-like molecular ruler that determines the length of salmonella’s bacteria needle, according to a new University of Utah study by doctoral student Daniel Wee and biology professor Kelly Hughes. Credit: Daniel Wee, University of Utah

The news release also offers some specific details about the research,

How the study was performed

The new study used the Typhimurium strain of Salmonella enterica, which causes food poisoning. The researchers proved the molecular ruler determines needle length in salmonella by inserting amino acids from the plague bacterium’s molecular ruler genes into genes for salmonella’s molecular ruler, making rulers with seven different lengths.

Genetically engineered salmonella with seven ruler lengths were grown in a flask, their needles isolated, and the needle lengths measured under an electron microscope.

Wee found the ruler lengths correlated precisely with the lengths of the resulting needles or injectisomes, with each amino acid added to the ruler gene making the resulting needle 0.2 nanometers longer.

Previous studies found the molecular ruler determines the length of the hook or U-joint that helps turn flagella or propellers in many bacteria. Research also found the molecular ruler determines the length of both the flagellar hook and the needle in plague bacteria. But some researchers argued salmonella needle’s length was determined by some other mechanism:

– One theory holds that a molecular measuring cup in the needle’s base sends a cupful of needle components to assemble the needle, and the length of the needle is determined by the size of the cup. The new study disproved that by genetically removing the cup and showing that the injectisomes or needles still grew to correct lengths.

– Another theory says that as needle components assemble outside the needle’s base, a rod-shaped structure assembles inside the base to link the base and needle, and that when the rod is complete, needle assembly stops, thus determining needle length. But the Utah study found the rod and needle components are not made simultaneously, but compete with each other, so as more rod parts are made, fewer needle parts are made, giving an illusion that rod completion controls needle length.

Here’s a link to and a citation for the paper,

Molecular ruler determines needle length for the Salmonella Spi-1 injectisome by Daniel H. Wee and Kelly T. Hughes. Published online before print March 16, 2015, doi: 10.1073/pnas.1423492112 PNAS March 16, 2015

This paper is behind a paywall.

 

MMA (mixed martial arts) and nano silver wound dressings

I had never, ever expected to mention mixed martial arts (MMA) here but that’s one of the delightful aspects of writing about nanotechnology; you never know where it will take you. A March 9, 2015 news item on Azonano describes the wound situation for athletes and a new product,

..

As an MMA Champion athlete, Rich Franklin knows all too well about germs and how easily they spread. During training he dealt with them on a regular basis, but it wasn’t until the first time he had staph, did he realize these infections could cost him a victory. Now, working in a global setting, Franklin trains in locations around the world which leaves him exposed to a plethora of bacteria and fungi. So he teamed up with American Biotech Labs (ABL) to develop Armor Gel, nano silver-based, wound dressing gel that can stay active on the skin for up to seventy-two hours (3 days). Using patented nano silver technology, Armor Gel has been scientifically tested to reduce the levels of bacteria and other pathogens, while forming a protective barrier “armor” over the wound. By shielding the body from external bacterial, the body’s natural healing process can be expedited. Its use is recommended by doctors, trainers, coaches, and athletes alike.

A March 6, 2015 ABL news release on BusinessWire, which originated the news item, provides a little more detail about Armor Gel,

Engineered for today’s modern athletes, Armor Gel is safe, nontoxic and provides a personal first line of defense. Already proven to reduce the levels of MRSA, VRE, pseudomonas aeruginosa, E. coli, A. niger and Candida albicans, Armor Gel is formulated using a unique and patented 24 SilverSol Technology®.

American Biotech Labs (ABL) was started in 2002 as a nano silver biotech company with the goal of creating a more stable and powerful silver technology for consumer products. …

I am providing a link to the product website (neither the link nor this post are endorsements), you can find out more about Armor Gel here.

Armor Gel was announced previously in a Sept. 16, 2014 ABL news release on PR Newswire, At the time no mention was made of Rich Franklin, their MMA athlete,

American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products.  The new products will allow American Biotech Labs (ABL) to market in the wound-care market focusing on ultimate sports and fitness, spa and health, and animal markets.

The new over-the-counter (OTC) products will have wound-dressing claims for minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations.  The products also have pathogen-inhibiting barrier claims against pathogens, such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, MRSA and VRE, as well as fungi, such as Candida albicans and Aspergillus niger.  These new gels can provide a barrier that will help protect wounds for 24 to 72 hours.

The new products will be found under the names of Armor Gel™ (for the ultimate sports and fitness market), ASAP OTC™ (for the spa and health markets), and ASAP Pet Shield® (for the animal market).

Along with the release of these new products, ABL has formed a strategic alliance with Stuart Evey, founder and former chairman of ESPN, and Gary Bernstein, marketing executive and professional photographer and film maker.  ABL will utilize these talented individuals to help introduce these revolutionary new products to high-profile organizations in sports, pet stores, fashion and beauty, medical, and direct-marketing areas, etc.

Said Keith Moeller, ABL Director, “We are very grateful to the numerous top scientists, labs and universities that have helped move this amazing, patented, silver technology forward.  We believe that these products have the ability to impact the future of wound management worldwide.”

Note: Any statements released by American Biotech Labs, LLC that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company’s business prospects and performance.

You can find out more about ABL and its entire product line here.